ACAD
16.91
-1.32
-7.24%
AEMD
4.68
+0.09
+1.96%
APRI
1.16
-0.03
-2.52%
ARNA
1.43
-0.05
-3.38%
ATEC
0.21
+0.02
+9.26%
CNAT
1.563
-0.088
-5.3030%
CRXM
0.23
+0.001
+0.4369%
CYTX
0.132
-0.008
-5.6429%
DXCM
57.149
-1.111
-1.907%
GNMK
4.95
-0.01
-0.20%
HALO
7.33
+0.16
+2.23%
ILMN
136.3
-2.4
-1.73%
INNV
0.05
-0.001
-1.0000%
INO
6.19
+0.41
+7.09%
ISCO
2.61
-0.19
-6.79%
ISIS
57.56
0.00
0.00%
LGND
85.925
-2.335
-2.646%
LPTN
0.15
-0.01
-6.3007%
MBVX
0.525
0.00
0.00%
MEIP
0.98
-0.03
-2.97%
MNOV
4.15
-0.07
-1.66%
MRTX
18.72
-0.82
-4.20%
MSTX
0.235
+0.005
+2.174%
NBIX
33.8
+0.1
+0.30%
NUVA
41.415
-0.275
-0.660%
ONCS
1.509
+0.029
+1.959%
ONVO
1.93
+0.01
+0.52%
OREX
1.56
-0.09
-5.45%
OTIC
13.45
+0.25
+1.89%
QDEL
15.22
-0.18
-1.17%
RCPT
231.96
0.00
0.00%
RGLS
5.63
-0.05
-0.88%
RMD
56.46
-1.28
-2.22%
SCIE
0.001
+0.00
+12.5000%
SPHS
1.56
-0.08
-4.88%
SRNE
4.545
+0.045
+1.000%
TROV
3.674
-0.116
-3.061%
VICL
0.31
-0.01
-3.03%
VOLC
18
0.00
0.00%
ZGNX
9.18
+0.07
+0.7673%
ACAD
16.91
-1.32
-7.24%
AEMD
4.68
+0.09
+1.96%
APRI
1.16
-0.03
-2.52%
ARNA
1.43
-0.05
-3.38%
ATEC
0.21
+0.02
+9.26%
CNAT
1.563
-0.088
-5.3030%
CRXM
0.23
+0.001
+0.4369%
CYTX
0.132
-0.008
-5.6429%
DXCM
57.149
-1.111
-1.907%
GNMK
4.95
-0.01
-0.20%
HALO
7.33
+0.16
+2.23%
ILMN
136.3
-2.4
-1.73%
INNV
0.05
-0.001
-1.0000%
INO
6.19
+0.41
+7.09%
ISCO
2.61
-0.19
-6.79%
ISIS
57.56
0.00
0.00%
LGND
85.925
-2.335
-2.646%
LPTN
0.15
-0.01
-6.3007%
MBVX
0.525
0.00
0.00%
MEIP
0.98
-0.03
-2.97%
MNOV
4.15
-0.07
-1.66%
MRTX
18.72
-0.82
-4.20%
MSTX
0.235
+0.005
+2.174%
NBIX
33.8
+0.1
+0.30%
NUVA
41.415
-0.275
-0.660%
ONCS
1.509
+0.029
+1.959%
ONVO
1.93
+0.01
+0.52%
OREX
1.56
-0.09
-5.45%
OTIC
13.45
+0.25
+1.89%
QDEL
15.22
-0.18
-1.17%
RCPT
231.96
0.00
0.00%
RGLS
5.63
-0.05
-0.88%
RMD
56.46
-1.28
-2.22%
SCIE
0.001
+0.00
+12.5000%
SPHS
1.56
-0.08
-4.88%
SRNE
4.545
+0.045
+1.000%
TROV
3.674
-0.116
-3.061%
VICL
0.31
-0.01
-3.03%
VOLC
18
0.00
0.00%
ZGNX
9.18
+0.07
+0.7673%
Home » Archive by Category

Xconomy

Heart Drug Safety Concerns Prompt Shutdown at Laguna Pharmaceuticals

December 6, 2015 – 9:31 am

San Diego’s Laguna Pharmaceuticals has shut down, after early results from a late-stage trial of the company’s lone drug candidate revealed previously unseen safety concerns. “If you’re going to…

[[Click headline to continue reading.]]

West Coast Bio Roundup: Gene Edit Talk, Not Poor ORIC, BioMarin Sags

December 4, 2015 – 6:34 am

[Corrected, 12/4/15, 5:10pm. See below.] In Washington, DC, this week, a three-day meeting brought together scientists, ethicists, and others to discuss the blistering advances in gene editing and…

[[Click headline to continue reading.]]

West Coast Bio Roundup: Gene Edit Talk, Not Poor ORIC, BioMarin Sags

December 4, 2015 – 6:34 am

[Corrected, 12/4/15, 5:10pm. See below.] In Washington, DC, this week, a three-day meeting brought together scientists, ethicists, and others to discuss the blistering advances in gene editing and…

[[Click headline to continue reading.]]

San Diego’s GreatCall Buys Lively’s Assets

December 3, 2015 – 6:24 pm

San Diego-based GreatCall, the mobile virtual network operator targeting the 65+ market, says today it has acquired the assets of Lively, a three-year-old San Francisco startup offering gadgets and…

[[Click headline to continue reading.]]

Avalon, TPG Lead $15M Deal to Advance Metformin as Cancer Drug

December 3, 2015 – 6:00 pm

Metformin has long been the first-line drug of choice for treating type 2 diabetes. While insulin may be better known (it’s been available since the 1920s), metformin was introduced in the UK in 1958…

[[Click headline to continue reading.]]

Gene Edit Summit Leaders Stop Shy Of Call To Ban Germline Changes

December 3, 2015 – 3:08 pm

No call for a ban. No moratorium. But the scientists and ethicists who convened this week’s once-in-a-generation summit in Washington, DC, say that the practice of editing human DNA in a way…

[[Click headline to continue reading.]]

Led By Biotech Stars, ORIC Nabs $53M To Fight Drug-Resistant Cancer

December 2, 2015 – 5:25 am

Rich Heyman twice made hay developing drugs to treat cancers that depend on hormones to thrive. Now he’s trying it again with a new company markedly different than the previous two. Heyman…

[[Click headline to continue reading.]]

What Three Biotechs Could Tell Us About The Pfizer-Allergan Merger

December 1, 2015 – 12:05 pm

The long-speculated Pfizer-Allergan merger, announced last week with a $160 billion price tag, is officially in motion and lurching toward inevitability. Inevitability doesn’t equal certainty…

[[Click headline to continue reading.]]

Human Longevity Buys Software Specialist Cypher Genomics

November 30, 2015 – 12:12 pm

[Updated 11/30/2015 at 9:25 pm. See below.] Human Longevity, the San Diego startup founded by human genome pioneer J. Craig Venter, said today it has acquired San Diego-based Cypher…

[[Click headline to continue reading.]]

New Bio Fund Partner Describes A16Z Investment Strategy

November 25, 2015 – 8:08 am

When Marc Andreessen and Ben Horowitz founded their namesake venture firm in 2009, they laid out a clear-but-narrow vision for investing in a new wave of Web-based innovation. Andreessen, in…

[[Click headline to continue reading.]]